Widening bottlenecks in drug discovery: glimpses from Drug Discovery Technology Europe 2005.

Keywords

Drug discovery, Drug, Data science, Computational biology, Pharmacology

References

• Bob Ruffolo discusses the rhythm of drug development.Bob Ruffolo, Katharine Barnes — 2004
• Ligand efficiency: a useful metric for lead selection.Andrew L. Hopkins, Colin R. Groom, Alexander Alex — 2004
• The maximal affinity of ligands.Irwin D. Kuntz, K. Chen, Kim A. Sharp — 1999
• Fragment-based lead discovery using X-ray crystallography.Michael J. Hartshorn, Christopher W. Murray, Anne Cleasby — 2005

Cited by

• Reinforcement learning design for cancer clinical trialsYufan Zhao, Michael R. Kosorok, Donglin Zeng — 2009
• A Gentle Introduction to Reinforcement Learning and its Application in Different FieldsMuddasar Naeem, Syed Tahir Hussain Rizvi, Antonio Coronato — 2020

Related papers

• People's Drug Guide to Deadly Drug Interactions Focuses on Drug/Drug, Drug/Food, and Drug/Vitamin Interactions:J. Shadley — 1998
• Me-too drug,me-better drug and me-new drug in drug R&DZhu Bao-quan — 2009
• Using model-system genetics for drug-based target discovery.David J. Matthews, Jenny Kopczynski — 2001
• Structural biology and drug discovery.Miles Congreve, Christopher W. Murray, Tom L. Blundell — 2005
• The use of constitutively active GPCRs in drug discovery and functional genomicsDerek Chalmers, Dominic P. Behan — 2002
• Functional cell-based uHTS in chemical genomic drug discovery.Glenn Croston — 2002